Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Related
Posts
Support letter for inclusion of Daclatasvir on 4th March, 2015.
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Community group taking actions to enable greater access for generic HCV treatment
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
